These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33237904)
21. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer]. Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364 [TBL] [Abstract][Full Text] [Related]
22. Blood pressure and risk of cancer: a Mendelian randomization study. Chan II; Kwok MK; Schooling CM BMC Cancer; 2021 Dec; 21(1):1338. PubMed ID: 34915881 [TBL] [Abstract][Full Text] [Related]
23. Blood Pressure and Risk of Cardiovascular Disease in UK Biobank: A Mendelian Randomization Study. Wan EYF; Fung WT; Schooling CM; Au Yeung SL; Kwok MK; Yu EYT; Wang Y; Chan EWY; Wong ICK; Lam CLK Hypertension; 2021 Feb; 77(2):367-375. PubMed ID: 33390054 [TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population. Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404 [TBL] [Abstract][Full Text] [Related]
25. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Carreón T; Ruder AM; Schulte PA; Hayes RB; Rothman N; Waters M; Grant DJ; Boissy R; Bell DA; Kadlubar FF; Hemstreet GP; Yin S; LeMasters GK Int J Cancer; 2006 Jan; 118(1):161-8. PubMed ID: 16003747 [TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. McGrath M; Michaud D; De Vivo I BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins. Szymańska B; Pawlik KJ; Sawicka E; Dembowski J; Kowal P; Zdrojowy R; Długosz A Adv Clin Exp Med; 2017 Oct; 26(7):1069-1075. PubMed ID: 29211353 [TBL] [Abstract][Full Text] [Related]
28. Slow N-acetylation as a possible contributor to bladder carcinogenesis. El Kawak M; Dhaini HR; Jabbour ME; Moussa MA; El Asmar K; Aoun M Mol Carcinog; 2020 Sep; 59(9):1017-1027. PubMed ID: 32529781 [TBL] [Abstract][Full Text] [Related]
29. Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men. Teleka S; Orho-Melander M; Liedberg F; Melander O; Jirström K; Stocks T Sci Rep; 2022 Oct; 12(1):18336. PubMed ID: 36316463 [TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. Leibovici D; Grossman HB; Dinney CP; Millikan RE; Lerner S; Wang Y; Gu J; Dong Q; Wu X J Clin Oncol; 2005 Aug; 23(24):5746-56. PubMed ID: 16110031 [TBL] [Abstract][Full Text] [Related]
31. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking. Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945 [TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782 [TBL] [Abstract][Full Text] [Related]
33. Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. Deitz AC; Rothman N; Rebbeck TR; Hayes RB; Chow WH; Zheng W; Hein DW; García-Closas M Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1543-6. PubMed ID: 15342459 [TBL] [Abstract][Full Text] [Related]
34. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441 [TBL] [Abstract][Full Text] [Related]
35. Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study. Regev-Avraham Z; Baron-Epel O; Hammond SK; Keinan-Boker L Breast Cancer; 2018 Mar; 25(2):176-184. PubMed ID: 29071579 [TBL] [Abstract][Full Text] [Related]
36. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Lubin JH; Kogevinas M; Silverman D; Malats N; Garcia-Closas M; Tardón A; Hein DW; Garcia-Closas R; Serra C; Dosemeci M; Carrato A; Rothman N Int J Epidemiol; 2007 Feb; 36(1):236-41. PubMed ID: 17510079 [TBL] [Abstract][Full Text] [Related]
37. Timing of Pubertal Development and Midlife Blood Pressure in Men and Women: A Mendelian Randomization Study. Chan II; Kwok MK; Schooling CM J Clin Endocrinol Metab; 2022 Jan; 107(1):e386-e393. PubMed ID: 34343299 [TBL] [Abstract][Full Text] [Related]
38. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Green J; Banks E; Berrington A; Darby S; Deo H; Newton R Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561 [TBL] [Abstract][Full Text] [Related]
39. Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese. Kontani K; Kawakami M; Nakajima T; Katsuyama T Urol Res; 2001 Jun; 29(3):199-204. PubMed ID: 11482447 [TBL] [Abstract][Full Text] [Related]
40. Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway. Hektoen HH; Robsahm TE; Andreassen BK; Stenehjem JS; Axcrona K; Mondul A; Gislefoss RE Cancer Med; 2020 Jun; 9(12):4420-4432. PubMed ID: 32319230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]